日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations

COVID-19 大流行期间骨转移和癌症治疗引起的骨丢失的管理：国际视角和建议

期刊:Journal of Bone Oncology
影响因子:3.5
doi:10.1016/j.jbo.2021.100375
Brown, J E; Wood, S L; Confavreux, C; Abe, M; Weilbaecher, K; Hadji, P; Johnson, R W; Rhoades, J A; Edwards, C M; Croucher, P I; Juarez, P; El Badri, S; Ariaspinilla, G; D'Oronzo, S; Guise, T A; Van Poznak, C
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Suppression of cancer-associated bone loss through dynamic mechanical loading

通过动态机械负荷抑制癌症相关的骨质流失

期刊:
影响因子:
doi:10.1016/j.bone.2021.115998
Pagnotti, G M; Thompson, W R; Guise, T A; Rubin, C T
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

Runx2 与前列腺癌患者病情进展的关联：介导骨溶解和成骨性转移性病变的机制

期刊:Oncogene
影响因子:7.3
doi:10.1038/onc.2009.389
Akech, J; Wixted, J J; Bedard, K; van der Deen, M; Hussain, S; Guise, T A; van Wijnen, A J; Stein, J L; Languino, L R; Altieri, D C; Pratap, J; Keller, E; Stein, G S; Lian, J B
肿瘤
前列腺癌
肿瘤免疫
发表日期：2010
文献求助 收藏

A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy.

一种经改造的hTERT启动子指导的溶瘤腺病毒复制，同时抑制TGFβ信号传导，用于乳腺癌治疗

期刊:Cancer Gene Therapy
影响因子:5
doi:10.1038/cgt.2009.72
Hu Z, Robbins J S, Pister A, Zafar M B, Zhang Z-W, Gupta J, Lee K J, Newman K, Yun C-O, Guise T, Seth P
信号转导
乳腺癌
肿瘤免疫
发表日期：2010
文献求助 收藏

Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis

甲状旁腺激素相关蛋白在人类乳腺癌介导的骨溶解发病机制中起因果作用的证据

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI118947
Guise, T A; Yin, J J; Taylor, S D; Kumagai, Y; Dallas, M; Boyce, B F; Yoneda, T; Mundy, G R
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：1996
文献求助 收藏